Viewing Study NCT00038402


Ignite Creation Date: 2025-12-25 @ 3:38 AM
Ignite Modification Date: 2025-12-26 @ 2:22 AM
Study NCT ID: NCT00038402
Status: COMPLETED
Last Update Posted: 2012-07-20
First Post: 2002-05-30
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer
Sponsor: M.D. Anderson Cancer Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: ID99-146
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View